Showing results (1481-1490 of 1,722) with videos related to
Sort By:
Pageof 173
International Journal of Chronic Obstructive Pulmonary Disease|January 11, 2020
Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPDMasakazu Ichinose, Yasushi Fukushima, Yoshikazu Inoue, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS TumorsMrinal M Gounder, Lakshmi Nayak, Solmaz Sahebjam, et al.JCO Oncology Practice|June 25, 2024
Low-Dose Planned Glucarpidase Allows Safe Outpatient High-Dose Methotrexate Treatment for CNS LymphomaLauren R Schaff, Dean Carlow, Ryan Schofield, et al.International Journal of Chronic Obstructive Pulmonary Disease|January 11, 2020
Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS StudyMasakazu Ichinose, Yasushi Fukushima, Yoshikazu Inoue, et al.Journal of Medicinal Chemistry|July 8, 2005
Synthesis and identification of [1,3,5]triazine-pyridine biheteroaryl as a novel series of potent cyclin-dependent kinase inhibitorsGee-Hong Kuo, Alan Deangelis, Stuart Emanuel, et al.Plos One|May 3, 2013
Acid ceramidase maintains the chondrogenic phenotype of expanded primary chondrocytes and improves the chondrogenic differentiation of bone marrow-derived mesenchymal stem cellsCalogera M Simonaro, Sylvain Sachot, Yi Ge, et al.AIDS (London, England)|September 10, 2003
Efficacy of indinavir-ritonavir-based regimens in HIV-1-infected patients with prior protease inhibitor failuresRafael E Campo, Jose N Moreno, German Suarez, et al.Plos One|July 23, 2011
Genetic variations strongly influence phenotypic outcome in the mouse retinaAustin S Jelcick, Yang Yuan, Barrett D Leehy, et al.Journal of Neuro-Oncology|June 29, 2011
Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomasFabio M Iwamoto, Andreas F Hottinger, Sasan Karimi, et al.Neuro-Oncology|August 12, 2011
Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomasFabio M Iwamoto, Andreas F Hottinger, Sasan Karimi, et al.Pageof 173